Among the 112 cases of low-grade meningiomas, GLUT3 positive expression was observed in 38 (33.9%), whereas among the 48 cases of high-grade meningiomas, GLUT3 positive expression was observed in 34 (70.8%). The gene discussed is SLC2A3; the disease is meningioma.